SEC Form 4 · accession 0001179110-16-024860
AMAG PHARMACEUTICALS INC. · AMAG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William K Heiden
Officer — CEO · Director
Period of report
May 16, 2016
Accepted (ET)
May 17, 2016 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792977
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 16, 2016 | F | 11,812 | $18.27 | A | 206,646 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 25,000 restricted stock units ("RSUs") on May 14, 2016. 11,812 shares were withheld on May 16, 2016 to satisfy the reporting person's applicable tax obligations, based on the closing price of the Issuer's common stock on May 13, 2016.